Effect of Enhanced Information, Values Clarification, and Removal of...
ImportancePrenatal genetic testing guidelines recommend providing patients with detailed information to allow informed, preference-based screening and diagnostic testing decisions. The effect of...
View ArticlePersonalized Genomic Medicine and Prenatal Genetic Testing
Just 30 years ago, Merkatz et al reported an association between low maternal serum alpha-fetoprotein and trisomy 18, proving in principal that information about a fetus could be learned prenatally....
View ArticleShould Life Insurers Have Access to Genetic Test Results?
This Viewpoint discusses the issues involved in granting insurance companies access to consumers’ genetic information.
View ArticleGenome-Scale Sequencing in Clinical Care Establishing Molecular Diagnoses and...
This Editorial discusses possible contributions of genomic sequencing to progress in clinical care, from molecular diagnosis to improved outcomes.
View ArticleA Stool DNA Test (Cologuard) for Colorectal Cancer Screening
The FDA has approved a stool DNA test to screen average-risk adults ≥50 years old for colorectal cancer.
View ArticleGenetic Testing and FDA Regulation Overregulation Threatens the Emergence of...
This Viewpoint discusses potential drawbacks of regulation meant to to ensure the quality, safety, and validity of laboratory-developed diagnostic tests.
View ArticleFDA Regulation of Laboratory-Developed Diagnostic Tests Protect the Public,...
Should the FDA regulate laboratory-developed diagnostic tests? —Yes.
View ArticleBreast Cancer Treatment Decision Making and Genetic Testing
This Viewpoint discusses the tension between increased availability of genetic testing and the usefulness of test results for clinical decision making in the context of breast cancer.
View ArticleClinical Genomics
This Viewpoint discusses sharing the underlying data of genetic testing to develop more precise disease risk estimates and understand whether physicians should act on them.
View Article
